Eng
Assessment of the safety and efficacy of the use of cultured autologous (allogenic) multipotent mesenchymal stromal cells from adipose tissue in patients with type 2 diabetes mellitus.
Assessment of the safety and efficacy of the use of neural crest-derived cells (NC-MSCs) in patients with the effects of spinal cord injury.
Evaluation of the safety and efficacy of the medical product containing cultured autologous fibroblasts in patients with age-related changes and/or scar tissue defects of facial skin.
Cellular therapy of female infertility of the uterine genesis against the background of endometrial hypoplasia.
Evaluation of the safety and efficacy of cultured multipotent mesenchymal stromal cells from human adipose tissue in the treatment of burn wounds.
Evaluation of the safety and efficacy of cultured multipotent mesenchymal stromal cells from human adipose tissue in the treatment of purulent wounds.
Evaluation of the safety and efficacy of the application of cultured autologous and allogenic multipotent mesenchymal stromal cells in patients with neurocompression syndrome due to herniated nucleus pulposus.
Evaluation of the safety and efficacy of transplantation of cultured autologous multipotent mesenchymal stromal cells from bone marrow in patients with prolonged bone fracture healing and in patients with traumatic bone tissue defects.
Evalution of the safety and efficacy of the medical product of cultured autoimmune neural crest derivatives (NCDs) in patients with remitting multiple sclerosis.
